The traditional drug development pipeline is marred by high failure rates and inefficiencies, largely due to unreliable and non-translating research models. VALID focuses on addressing this critical issue using advanced/complex hiPSC-derived models with increased predictive validity. Transforming Dr... Read more
This company has no offices yet